Age: 34.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Insomnia, Migraine, Mood swings, Night sweats, Premature menopause
Clinical narrative: premature ovarian failure/severe night sweats/mood swings/difficulty sleeping/restless nights/migraines/early onset menopause/allergies worsen/abdominal cramping/chest pains, a heavy menstrual cycle; autoimmune injuries; vomiting; Plaintiff was 34 years when she received three dosages of Gardasil; Information has been received from a lawyer regarding a case in litigation and referred to a currently adult female patient (pt) (exact age not provided). Her other medical history, concurrent conditions and concomitant therapies were not provided.  On an unknown date (at the age of 34 years old), the pt was vaccinated with three dosages of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided), as recommended by her health care provider/ doctor with her consent, for prophylaxis (reported as for preventing cervical cancer) (Product administered to patient of inappropriate age). Pt had no symptoms following the first quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)  vaccination. Following the second and third quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)  vaccinations, pt began to have severe night sweats, mood swings, restless nights, difficulty sleeping, and migraines. Her allergies worsened. Following the third quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)  vaccination, her doctor suspected premature ovarian failure and had her stop Depo-Provera so he could get accurate testing results as Depo-Provera could mask the symptoms of premature ovarian failure and impact the results. Pt's menstrual period started two weeks prior to stopping Depo-Provera and was ongoing at the time she stopped the shot. After she stopped the Depo-Provera, she had severe abdominal cramping, chest pains, night sweats, migraines that led to vomiting, and a heavy menstrual cycle which lasted for nine weeks steady. Pt's doctor suspected premature ovarian failure, as well as early onset menopause (Premature menopause). Pt contended that her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)  injection(s) caused her to develop serious and debilitating autoimmune injuries (Autoimmune disorder), including but not limited to Premature ovarian failure/premature menopause, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), pt had suffered and continued to suffer severe and permanent physical injuries and permanent emotional injuries, including pain and suffering. Pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her autoimmune disease and other injuries caused by human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and she would continue to incur these losses and expenses in the future. The outcome of all events (except for Product administered to patient of inappropriate age) was considered to be not recovered. The lawyer considered all events to be related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).  The lawyer considered all events (except for Product administered to patient of inappropriate age) to be disabling/incapacitating.